Abstract

Abstract'Plate‐like‐coral' shaped polymer capsule (PC‐PLCDB) with dendritic network structure and porous channels has been synthesized and used for therapeutic purposes. First di‐block copolymer [(PEG)‐b‐(L‐AspA)n] has been synthesized from PEG (polyethylene glycol) and aspartic acid (AspA). Then the biocompatible PC‐PLCDB has been achieved by homogeneous mixing of [(PEG)‐b‐(L‐AspA)n] and poly‐N‐isopropyl acrylamide (PNIPAM) followed by reprecipitation. Only H‐bonding is responsible for the foundation of self‐assembly of the polymer chains and to form PC‐PLCDB. A huge extent of loading anticancer drug, for example, doxorubicin (DOX) in PC‐PLCDB is possible. in vitro study has been performed to check the therapeutic efficacy of PC‐PLCAD‐DOX formulation on chronic myeloid leukemia cells (K562). The IC50 has been calculated to be 0.405 (±0.014) ng μg−1 of the formulation. PC‐PLCAD‐DOX inhibits 80% of the cancer cell only by 1.0 μg mL−1 of the formulation. This study reveals that the PC‐PLCAD could be a promising candidate for therapeutic applications.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.